Yüklüyor...
KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies
Survival of patients with metastatic CRC (mCRC) has improved steadily over the past several decades, due largely to the development of new combinations of standard chemotherapy, as well as to the introduction of new targeted therapies. Among the available targeted therapies are two monoclonal antibo...
Kaydedildi:
| Materyal Türü: | Makale |
|---|---|
| Dil: | en |
| Baskı/Yayın Bilgisi: |
Multimed Inc.
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2901795/ https://ncbi.nlm.nih.gov/pubmed/20680106 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|